EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy

Xinzhe Feng, Shanbang Zhu, Zhou Ji, Changhao Han, Chenxu Liu, Zhi Li, Yihong Xu, Weidong Xu

Chemical Engineering Journal · 2026-11 · 184401

DOI: 10.1016/j.cej.2026.184401 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Engineering Journal, 2026-11. Verfasst von Xinzhe Feng und 7 weiteren Autor:innen. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The First Affiliated Hospital of Naval Medical University, National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a whole-joint disorder characterized by cartilage degradation, synovial inflammation, and subchondral bone remodeling, yet disease-modifying therapies remain limited. Here, we developed an injectable microsphere system (S-Exo@HAMA@PLL) composed of synovial mesenchymal stem cells-derived exosomes associated with recombinant sTREM2 and encapsulated in poly- l -lysine-coated methacrylated hyaluronic acid microspheres. The intraluminal encapsulation efficiency of exosomes within HAMA hydrogels reached approximately 75% by BCA protein quantification and 80–95% recovery of exosomal CD63/CD9 signals after microsphere dissolution, while hemolysis remained below 5% at therapeutically relevant concentrations. S-Exo@HAMA@PLL prolonged intra-articular retention for up to 28 days, reduced oxidative stress, shifted macrophages toward an anti-inflammatory CD206 + /CD163 + phenotype, and restored the balance between matrix-degrading enzymes (MMP13 and ADAMTS5) and cartilage matrix components (COL2A1 and ACAN) in IL-1β-stimulated chondrocyte/macrophage co-culture and in an OA mouse model. Co-culture and pharmacological-perturbation data were consistent with coordinated reductions in PI3K-AKT phosphorylation in macrophages and MAPK13/ERK/JNK-related stress signals in chondrocytes following S-Exo@HAMA@PLL treatment. With demonstrated biocompatibility, inflammation-associated joint retention under the tested conditions, and favorable OA-related outcomes in the tested models, this exosome-based microsphere system represents a promising strategy for OA treatment.

Förderung

  • The First Affiliated Hospital of Naval Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Feng, X., Zhu, S., Ji, Z., Han, C., Liu, C., Li, Z., Xu, Y., & Xu, W. (2026). A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy. Chemical Engineering Journal, 184401. https://doi.org/10.1016/j.cej.2026.184401

Vancouver

Feng X, Zhu S, Ji Z, Han C, Liu C, Li Z, et al. A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy. Chemical Engineering Journal. 2026:184401. doi:10.1016/j.cej.2026.184401

BibTeX
@article{Feng2026,
  author = {Feng, Xinzhe and Zhu, Shanbang and Ji, Zhou and Han, Changhao and Liu, Chenxu and Li, Zhi and Xu, Yihong and Xu, Weidong},
  title = {A sTREM2-exosome-based therapeutic platform reprograms macrophage polarization and chondrocyte homeostasis for osteoarthritis therapy},
  journal = {Chemical Engineering Journal},
  year = {2026},
  pages = {184401},
  doi = {10.1016/j.cej.2026.184401}
}
Kostenlos starten →